Prospera Financial Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.88M | Buy |
19,441
+10,913
| +128% | +$4.43M | 0.15% | 151 |
|
|
2025
Q1 | $4.24M | Buy |
8,528
+1,026
| +14% | +$511K | 0.1% | 226 |
|
|
2024
Q4 | $3.9M | Buy |
7,502
+2,953
| +65% | +$1.54M | 0.09% | 234 |
|
|
2024
Q3 | $2.82M | Buy |
4,549
+746
| +20% | +$462K | 0.07% | 281 |
|
|
2024
Q2 | $2.1M | Buy |
3,803
+997
| +36% | +$552K | 0.06% | 327 |
|
|
2024
Q1 | $1.63M | Buy |
2,806
+187
| +7% | +$109K | 0.05% | 376 |
|
|
2023
Q4 | $1.39M | Sell |
2,619
-368
| -12% | -$195K | 0.05% | 385 |
|
|
2023
Q3 | $1.51M | Sell |
2,987
-394
| -12% | -$200K | 0.06% | 325 |
|
|
2023
Q2 | $1.77M | Buy |
3,381
+305
| +10% | +$159K | 0.07% | 285 |
|
|
2023
Q1 | $1.77M | Sell |
3,076
-30
| -1% | -$17.3K | 0.07% | 285 |
|
|
2022
Q4 | $1.71M | Buy |
3,106
+274
| +10% | +$151K | 0.09% | 256 |
|
|
2022
Q3 | $1.44M | Buy |
2,832
+77
| +3% | +$39.1K | 0.08% | 292 |
|
|
2022
Q2 | $1.5M | Sell |
2,755
-46
| -2% | -$25K | 0.08% | 294 |
|
|
2022
Q1 | $1.66M | Buy |
2,801
+1,095
| +64% | +$647K | 0.07% | 314 |
|
|
2021
Q4 | $1.14M | Sell |
1,706
-116
| -6% | -$77.4K | 0.05% | 380 |
|
|
2021
Q3 | $1.04M | Sell |
1,822
-254
| -12% | -$145K | 0.05% | 360 |
|
|
2021
Q2 | $1.05M | Sell |
2,076
-39
| -2% | -$19.7K | 0.05% | 368 |
|
|
2021
Q1 | $964K | Sell |
2,115
-90
| -4% | -$41K | 0.06% | 349 |
|
|
2020
Q4 | $1.03M | Buy |
2,205
+2,039
| +1,228% | +$950K | 0.07% | 291 |
|
|
2020
Q3 | $73K | Sell |
166
-876
| -84% | -$385K | 0.03% | 500 |
|
|
2020
Q2 | $377K | Buy |
1,042
+94
| +10% | +$34K | 0.03% | 399 |
|
|
2020
Q1 | $269K | Buy |
+948
| New | +$269K | 0.03% | 415 |
|
|
2018
Q3 | – | Sell |
-1,052
| Closed | -$218K | – | 454 |
|
|
2018
Q2 | $218K | Sell |
1,052
-147
| -12% | -$30.5K | 0.03% | 415 |
|
|
2018
Q1 | $250K | Buy |
+1,199
| New | +$250K | 0.03% | 377 |
|